Document is current
Any future updates will be listed below
-
Authors
El Baba, Ala https://orcid.org/0000-0001-7518-3225
Jeimy, Samira
Soller, Lianne
Kim, Harold
Begin, Philippe
Chan, Edmond S.
-
Funding
Funding for this research was provided by:
Fonds de Recherche du Québec - Santé (281662)
BC Children’s Foundation
- License Information
-
More Information
Article History
Received: 9 November 2022
Accepted: 8 December 2022
First Online: 17 January 2023
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Ala El Baba declares that they have no competing interests. Dr. Lianne Soller declares that they have no competing interests. Dr. Edmond Chan has received research support from DBV Technologies; and has been a member of advisory boards for Pfizer, Pediapharm, Leo Pharma, Kaleo, DBV, AllerGenis, Sanofi Genzyme, Bausch Health, Avir Pharma. Dr. Philip Bégin has received research support from DBV Technologies, Novartis, Sanofi and Regeneron; and has been a member of advisory boards/speaker’s bureau for Pfizer, DBV, Sanofi Genzyme, Bausch Health, Novartis, Aralez and ALK. Dr. Samira Jeimy has been on speaker’s bureaus for Aralez, AstraZeneca, GSK, Sanofi, and Novartis, and on advisory boards for Sanofi and Aralez. Dr. Harold Kim has served on speakers’ bureau and/or advisory boards: AstraZeneca, Aralez, Bausch Health, CSL Behring, GSK, Kaleo, Novartis, Pediapharm, Pfizer, Sanofi, Shire, Takeda.
